Archive: 11/11/2014

Professor helps develop promising Ebola drug

As the Ebola crisis in Africa continues and concern ramps up in the United States, a pharmaceutical company with a Corvallis connection is ready to respond with a limited amount of a potentially promising new drug.

Why Ebola needs a measured response

The poor public health infrastructure in West Africa is what has made the Ebola epidemic so deadly, and quarantines against the disease in the U.S. are counterproductive. Physicians also need to play a more prominent role ...

page 7 from 9